Table 2.
Characteristic | Number (%) | cfPWV (m/s) | P value | |
---|---|---|---|---|
Gender | Male | 63 (67.7) | 10.07 ± 2.60 | 0.869 |
Female | 30 (32.3) | 10.17 ± 3.25 | ||
| ||||
Diabetes | No | 49 (52.7) | 9.37 ± 2.52 | 0.007∗ |
Yes | 44 (47.3) | 10.92 ± 2.92 | ||
| ||||
Dyslipidemia | No | 49 (52.7) | 9.50 ± 2.38 | 0.029∗ |
Yes | 44 (47.3) | 10.77 ± 3.11 | ||
| ||||
Hypertension | No | 56 (60.2) | 9.93 ± 2.80 | 0.473 |
Yes | 37 (39.8) | 10.36 ± 2.85 | ||
| ||||
ACE inhibitor | No | 77 (82.8) | 10.11 ± 2.83 | 0.973 |
Yes | 16 (17.2) | 10.08 ± 2.79 | ||
| ||||
ARB | No | 67 (72.0) | 9.95 ± 2.80 | 0.409 |
Yes | 26 (28.0) | 10.49 ± 2.85 | ||
| ||||
β-Blocker | No | 71 (76.3) | 10.07 ± 2.09 | 0.841 |
Yes | 22 (23.7) | 10.21 ± 2.61 | ||
| ||||
CCB | No | 71 (76.3) | 9.98 ± 2.74 | 0.457 |
Yes | 22 (23.7) | 10.49 ± 3.05 | ||
| ||||
Statins | No | 70 (75.3) | 10.19 ± 2.91 | 0.583 |
Yes | 23 (24.7) | 9.82 ± 2.52 | ||
| ||||
Fibrate | No | 75 (80.6) | 10.11 ± 2.84 | 0.937 |
Yes | 18 (19.4) | 10.06 ± 2.74 |
Data are expressed as means ± standard deviations.
∗ P < 0.05 was considered statistically significant after Student's t-test.
cfPWV, carotid-femoral pulse wave velocity; CAD, coronary artery disease; CHF, congestive heart failure; ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; CCB, calcium-channel blocker.